{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:35:40Z","timestamp":1792136140328,"version":"4.4.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1097\/01.aco.0000192779.17151.65","type":"journal-article","created":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T04:04:10Z","timestamp":1139285050000},"page":"52-58","source":"Crossref","is-referenced-by-count":15,"title":["Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism"],"prefix":"10.1097","volume":"19","author":[{"given":"Johann","family":"Motsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd W.","family":"B\u00f6ttiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"R2-9-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2001-14668","article-title":"Epidemiology of venous thromboembolism","volume":"1","author":"Kearon","year":"2001","journal-title":"Semin. Vasc. Med."},{"key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(04)16004-2","article-title":"Pulmonary embolism","volume":"363","author":"Goldhaber","year":"2004","journal-title":"Lancet"},{"key":"R4-9-20210129","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"Heit","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1378\/chest.123.6.1947","article-title":"Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism","volume":"123","author":"Pryszcyk","year":"2003","journal-title":"Chest"},{"key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/01.CIR.0000064898.51892.09","article-title":"Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism","volume":"107","author":"Kucher","year":"2003","journal-title":"Circulation"},{"key":"R7-9-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"R8-9-20210129","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinte.163.11.1285","article-title":"The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event; a metaanalysis","volume":"163","author":"Van Dongen","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"R9-9-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF03041030","article-title":"The risk of recurrent venous thromboembolism: the Austrian Study on recurrent venous thromboembolism","volume":"115","author":"Kyrle","year":"2003","journal-title":"Wien. Klin. Wochenschr."},{"key":"R10-9-20210129","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1067\/mva.2001.116803","article-title":"Deep venous thrombosis in postoperative vascular surgical patients. A frequent finding without prophylaxis","volume":"34","author":"Hollyoak","year":"2001","journal-title":"J. Vasc. Surg."},{"key":"R11-9-20210129","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/01.CCM.0000171207.95319.B2","article-title":"Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors","volume":"33","author":"Cook","year":"2005","journal-title":"Crit. Care Med."},{"key":"R12-9-20210129","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2004.00720.x","article-title":"Extensive screening for malignant disease in idiopathic venous thromboembolism","volume":"2","author":"Piccioli","year":"2004","journal-title":"J. Thromb. Hemost."},{"key":"R13-9-20210129","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9610(96)00154-7","article-title":"Is deep vein thrombosis surveillance warranted in high-risk trauma patients?","volume":"172","author":"Piotrowski","year":"1996","journal-title":"Am. J. Surg."},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1378\/chest.128.2.958","article-title":"Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients","volume":"128","author":"Spouropoulos","year":"2005","journal-title":"Chest"},{"issue":"suppl.","key":"R15-9-20210129","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.sla.0000154120.96169.99","article-title":"A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals","volume":"241","author":"Tooher","year":"2005","journal-title":"Ann. Surg."},{"key":"R17-9-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa041533","article-title":"Electronic alerts to prevent venous thromboembolism among hospitalized patients","volume":"352","author":"Kucher","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"R18-9-20210129","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.CIR.0000137826.09715.9C","article-title":"Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials","volume":"110","author":"Wan","year":"2004","journal-title":"Circulation"},{"key":"R19-9-20210129","doi-asserted-by":"crossref","first-page":"401S","DOI":"10.1378\/chest.126.3_suppl.401S","article-title":"Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Buller","year":"2004","journal-title":"Chest"},{"key":"R20-9-20210129","article-title":"Fixed dose subcutaneous low molecular weight heparin versus adjusted dose unfractionated heparin for venous thromboembolism","author":"Van den Belt","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"R21-9-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","article-title":"Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized controlled trials","volume":"140","author":"Quinlan","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"R22-9-20210129","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","article-title":"Matisse Investigators. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial","volume":"140","author":"Buller","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"R23-9-20210129","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","article-title":"Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism","volume":"349","author":"Buller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"R24-9-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0037-1612901","article-title":"Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism","volume":"85","author":"Aschwanden","year":"2001","journal-title":"Thromb. Haemost."},{"key":"R25-9-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1615570","article-title":"Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism","volume":"82","author":"Schellong","year":"1999","journal-title":"Thromb. Haemost."},{"key":"R26-9-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"R27-9-20210129","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"R28-9-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism","volume":"349","author":"Kearon","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"R29-9-20210129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-141-4-200408170-00004","article-title":"Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial","volume":"141","author":"Prandoni","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"R30-9-20210129","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1538-7836.2005.01374.x","article-title":"New anticoagulants","volume":"3","author":"Weitz","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"R31-9-20210129","first-page":"1017","article-title":"Treatment of heparin-induced thrombocytopenia with fondaparinux","volume":"89","author":"Harenberg","year":"2004","journal-title":"Haematologica"},{"key":"R32-9-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2004-05-2010","article-title":"Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with heparin induced thrombo-cytopenia","volume":"105","author":"Savi","year":"2005","journal-title":"Blood"},{"key":"R33-9-20210129","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1001\/archinte.162.16.1833","article-title":"for the Steering Committees of the Pentasaccharide Orthopedic Prophylaxis studies. Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery. A meta-analysis of 4 randomized double-blind studies","volume":"162","author":"Turpie","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"R34-9-20210129","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.163.11.1337","article-title":"PENTasaccharide in Hip-FRAacture Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicentre, randomized, placebo-controlled, double-blind study","volume":"163","author":"Eriksson","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"Suppl. 1","key":"R35-9-20210129","article-title":"A randomized double-blind study to compare the efficacy and safety of fondaparinux with dalteparin in the prevention of venous thromboembolism after high-risk abdominal surgery: the Pegasus Study","volume":"1","author":"Agnelli","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"R36-9-20210129","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1538-7836.2005.01374.x","article-title":"New anticoagulants","volume":"3","author":"Weitz","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"R37-9-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1538-7836.2003.00516.x","article-title":"A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A phase II evaluation","volume":"2","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"R38-9-20210129","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.0000038501.87442.02","article-title":"Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers","volume":"106","author":"Bijsterfeld","year":"2002","journal-title":"Circulation"},{"key":"R39-9-20210129","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2003.04811.x","article-title":"Recombinant factor VIIa reverses the anticoagulant effect of the long-lasting pentasaccharide idraparinux in healthy volunteers","volume":"124","author":"Bijsterfeld","year":"2004","journal-title":"Br. J. Haematol."},{"key":"R40-9-20210129","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1046\/j.1538-7836.2003.00368.x","article-title":"Comparison of ximelagatran, an oral direct thrombin inhibitor with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study","volume":"1","author":"Colwell","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"R41-9-20210129","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(02)11469-3","article-title":"Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial","volume":"360","author":"Eriksson","year":"2002","journal-title":"Lancet"},{"key":"R42-9-20210129","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJMoa035162","article-title":"Comparison of ximelagatran with warfarin for prevention of venous thromboembolism after total knee replacement","volume":"349","author":"Francis","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"R43-9-20210129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.293.6.681","article-title":"Ginsberg JS and the THRIVE Treatment study Investigators. Ximelagatran vs. low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized Trial","volume":"293","author":"Fissinger","year":"2005","journal-title":"JAMA"},{"key":"R44-9-20210129","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa030104","article-title":"Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran","volume":"349","author":"Schulman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"R45-9-20210129","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/000313489906500906","article-title":"Bedside placement of inferior vena cava filters in the intensive care unit","volume":"65","author":"Tola","year":"1999","journal-title":"Am. Surg."},{"key":"R46-9-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"R47-9-20210129","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.amjsurg.2005.03.003","article-title":"Retrievable vena cava filters in trauma patients for high-risk prophylaxis and prevention of pulmonary embolism","volume":"189","author":"Allen","year":"2005","journal-title":"Am. J. Surg."},{"key":"R48-9-20210129","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10016-005-0025-1","article-title":"The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery","volume":"19","author":"Leon","year":"2005","journal-title":"Ann. Vasc. Surg."},{"key":"R49-9-20210129","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0735-1097(97)00319-7","article-title":"Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry","volume":"30","author":"Kasper","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"R50-9-20210129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/01.CIR.96.3.882","article-title":"Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry","volume":"96","author":"Konstantinides","year":"1997","journal-title":"Circulation"},{"key":"R51-9-20210129","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"R52-9-20210129","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000028422.51668.A2","article-title":"Importance of cardiac Troponin I and T in risk stratification of patients with acute pulmonary embolism","volume":"106","author":"Konstantinides","year":"2002","journal-title":"Circulation"},{"key":"R53-9-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0735-1097(92)90002-5","article-title":"PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2","volume":"20","author":"Dalla-Volta","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"R54-9-20210129","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/00003246-200111000-00027","article-title":"Thrombolysis during cardiopulmonary resuscitaion in fulminant pulmonary embolism: A review","volume":"29","author":"Ruiz-Bail\u00e9n","year":"2001","journal-title":"Crit. Care Med."},{"key":"R55-9-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00002018-200326060-00001","article-title":"Safety of thrombolysis during cardiopulmonary resuscitation","volume":"26","author":"Sp\u00f6hr","year":"2003","journal-title":"Drug Saf."},{"key":"R56-9-20210129","first-page":"41","article-title":"2-Richtlinie. Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungenembolie","volume":"34","author":"Interdisziplin\u00e4re","year":"2005","journal-title":"Phlebologie"},{"key":"R57-9-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-8703(99)70243-7","article-title":"Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism","volume":"138","author":"Tebbe","year":"1999","journal-title":"Am. Heart J."},{"key":"R58-9-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.resuscitation.2004.01.029","article-title":"Successful thrombolysis after pulmonary embolectomy for persistent massive postoperative pulmonary embolism","volume":"62","author":"Sp\u00f6hr","year":"2004","journal-title":"Resuscitation"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.aco.0000192779.17151.65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:09:47Z","timestamp":1785856187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001503-200602000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aco.0000192779.17151.65","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}